MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Clinical Lymphoma Myeloma & Leukemia
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

503 results · 1 filter active ·
Results by year
20102025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
503 works in the cohort · of 4,299,418page 10 of 11

Labels cover 1 of 503 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 503 of 503 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
AML-521 The Randomized Phase III SIERRA (Study of Iomab-B in Elderly Relapsed or Refractory AML) Trial: Successful Allogeneic Hematopoietic Stem Cell Transplantation Using Treatment With Iomab-B-Led Regimen for Patients With Active, Relapsed or Refractory AML With Failed Targeted Therapies
Rajneesh Nath, Stuart Seropian, Hannah Choe, Mark R. Litzow, Camille N. Abboud, Nebu Koshy +34 more
2023· article· en· Clinical Lymphoma Myeloma & Leukemia· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
affno abstractunlabeled
POSTER: MPN-346 INDEPENDENCE: Enrolling Phase III Trial to Study the Efficacy and Safety of Luspatercept versus Placebo in Patients With Myelofibrosis on JAK2 Inhibitor (JAK2i) Therapy Requiring Red Blood Cell Transfusions (RBCTs)
Jean‐Jacques Kiladjian, Claire Harrison, Ruben A. Mesa, Haifa Kathrin Al‐Ali, John Mascarenhas, Fabián Sanabria +3 more
2023· article· en· Clinical Lymphoma Myeloma & Leukemia· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affno abstractunlabeled
AML-197 Clinical Outcomes and Treatment Patterns in Adult Patients With FMS-Like Tyrosine Kinase 3 Internal Tandem Duplication Positive Acute Myeloid Leukemia Undergoing Allogeneic Hemopoietic Cell Transplantation in the US and Canada: CIBMTR® (Center for International Blood and Marrow Transplant Research Analysis)
Linda J. Burns, Bhavik J. Pandya, Karen Chen, Tao Wang, Bin Xie, Maelys Touya +5 more
2023· article· en· Clinical Lymphoma Myeloma & Leukemia· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
affno abstractunlabeled
POSTER: MPN-574 Characteristics and Clinical Outcomes in Patients With Polycythemia Vera Receiving Ruxolitinib After Hydroxyurea: A Longitudinal Analysis From the Prospective Observational Study of Patients With Polycythemia Vera in US Clinical Practices Trial (REVEAL)
Aaron T. Gerds, Michael R. Grunwald, Stephen T. Oh, Evan Braunstein, Zhenyi Xue, Valkal Bhat +2 more
2023· article· en· Clinical Lymphoma Myeloma & Leukemia· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affno abstractunlabeled
POSTER: AML-197 Clinical Outcomes and Treatment Patterns in Adult Patients With FMS-Like Tyrosine Kinase 3 Internal Tandem Duplication Positive Acute Myeloid Leukemia Undergoing Allogeneic Hemopoietic Cell Transplantation in the US and Canada: CIBMTR® (Center for International Blood and Marrow Transplant Research Analysis)
Linda J. Burns, Bhavik J. Pandya, Karen Chen, Tao Wang, Bin Xie, Maelys Touya +5 more
2023· article· en· Clinical Lymphoma Myeloma & Leukemia· Medicine
machine prediction:candidate · noneconsensus · none
0
citations

How this was built: Screen · Findings · About